Literature DB >> 23794729

Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012.

Scott Epperson1, Michael Jhung, Shawn Richards, Patricia Quinlisk, Lauren Ball, Mària Moll, Rachelle Boulton, Loretta Haddy, Matthew Biggerstaff, Lynnette Brammer, Susan Trock, Erin Burns, Thomas Gomez, Karen K Wong, Jackie Katz, Stephen Lindstrom, Alexander Klimov, Joseph S Bresee, Daniel B Jernigan, Nancy Cox, Lyn Finelli.   

Abstract

BACKGROUND. During August 2011-April 2012, 13 human infections with influenza A(H3N2) variant (H3N2v) virus were identified in the United States; 8 occurred in the prior 2 years. This virus differs from previous variant influenza viruses in that it contains the matrix (M) gene from the Influenza A(H1N1)pdm09 pandemic influenza virus. METHODS. A case was defined as a person with laboratory-confirmed H3N2v virus infection. Cases and contacts were interviewed to determine exposure to swine and other animals and to assess potential person-to-person transmission. RESULTS. Median age of cases was 4 years, and 12 of 13 (92%) were children. Pig exposure was identified in 7 (54%) cases. Six of 7 cases with swine exposure (86%) touched pigs, and 1 (14%) was close to pigs without known direct contact. Six cases had no swine exposure, including 2 clusters of suspected person-to-person transmission. All cases had fever; 12 (92%) had respiratory symptoms, and 3 (23%) were hospitalized for influenza. All 13 cases recovered. CONCLUSIONS. H3N2v virus infections were identified at a high rate from August 2011 to April 2012, and cases without swine exposure were identified in influenza-like illness outbreaks, indicating that limited person-to-person transmission likely occurred. Variant influenza viruses rarely result in sustained person-to-person transmission; however, the potential for this H3N2v virus to transmit efficiently is of concern. With minimal preexisting immunity in children and the limited cross-protective effect from seasonal influenza vaccine, the majority of children are susceptible to infection with this novel influenza virus.

Entities:  

Keywords:  influenza; public health; surveillance

Mesh:

Year:  2013        PMID: 23794729     DOI: 10.1093/cid/cit272

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  54 in total

1.  Factors associated with parental acceptance of influenza vaccination for their children: the evidence from four cities of China.

Authors:  Mingyi Zhao; Haiyan Liu; Shujuan Qu; Li He; Kathryn S Campy
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

Review 2.  Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface.

Authors:  Martha I Nelson; Amy L Vincent
Journal:  Trends Microbiol       Date:  2015-01-04       Impact factor: 17.079

3.  Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.

Authors:  Xiangjie Sun; Joanna A Pulit-Penaloza; Jessica A Belser; Claudia Pappas; Melissa B Pearce; Nicole Brock; Hui Zeng; Hannah M Creager; Natosha Zanders; Yunho Jang; Terrence M Tumpey; C Todd Davis; Taronna R Maines
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

4.  Reassortment between Swine H3N2 and 2009 Pandemic H1N1 in the United States Resulted in Influenza A Viruses with Diverse Genetic Constellations with Variable Virulence in Pigs.

Authors:  Daniela S Rajão; Rasna R Walia; Brian Campbell; Phillip C Gauger; Alicia Janas-Martindale; Mary Lea Killian; Amy L Vincent
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.

Authors:  Aitor Nogales; Laura Rodriguez; Caroline Chauché; Kai Huang; Emma C Reilly; David J Topham; Pablo R Murcia; Colin R Parrish; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity.

Authors:  Subrata Barman; John Franks; Jasmine C Turner; Sun-Woo Yoon; Robert G Webster; Richard J Webby
Journal:  Vaccine       Date:  2015-05-18       Impact factor: 3.641

7.  Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.

Authors:  James D Allen; Hyesun Jang; Joshua DiNapoli; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

8.  The emergence of influenza A (H3N2)v virus: what we learned from the first wave.

Authors:  Lyn Finelli; David L Swerdlow
Journal:  Clin Infect Dis       Date:  2013-07       Impact factor: 9.079

9.  A host-based RT-PCR gene expression signature to identify acute respiratory viral infection.

Authors:  Aimee K Zaas; Thomas Burke; Minhua Chen; Micah McClain; Bradly Nicholson; Timothy Veldman; Ephraim L Tsalik; Vance Fowler; Emanuel P Rivers; Ronny Otero; Stephen F Kingsmore; Deepak Voora; Joseph Lucas; Alfred O Hero; Lawrence Carin; Christopher W Woods; Geoffrey S Ginsburg
Journal:  Sci Transl Med       Date:  2013-09-18       Impact factor: 17.956

10.  Introductions and evolution of human-origin seasonal influenza a viruses in multinational swine populations.

Authors:  Martha I Nelson; David E Wentworth; Marie R Culhane; Amy L Vincent; Cecile Viboud; Matthew P LaPointe; Xudong Lin; Edward C Holmes; Susan E Detmer
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.